Articles · Biology
How Hot Flashes Work
Why the hypothalamus misfires, and what every treatment targets.
Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.
Hot flashes are the best-known symptom of menopause, yet most explanations stop at “falling estrogen causes them.” That is true but too vague to be useful. The mechanism was poorly understood for decades, which limited treatment to estrogen replacement or general symptom management. It is now well mapped, and that understanding is what made the first targeted non-hormonal treatment for hot flashes possible (fezolinetant, approved 2023). It also explains why every other option works.
The Comfort Zone for Body Temperature
Your body keeps core temperature within a narrow band, sometimes called the thermoregulatory null zone. Above the top edge, you sweat. Below the bottom edge, you shiver. In between, nothing fires. The hypothalamus watches and adjusts this band all the time.
In premenopausal women, the band is roughly 0.4 degrees Celsius wide.[1] In women with frequent hot flashes, it narrows to near zero, so almost any small change in temperature triggers a response.[1] This is why mild triggers, a warm room, a hot drink, stress, are enough to set off a flush. The calibration is wrong, and the error comes from the brain, not from the body’s actual temperature.
The KNDy Neurons
The mechanism behind this was found through research on a cluster of neurons in the hypothalamus called KNDy neurons.[2] The name is an acronym: these cells make three signalling molecules, kisspeptin (K), neurokinin B (N), and dynorphin (Dy).
KNDy neurons are best known for controlling reproductive hormones. They act as a pulse generator that drives the release of gonadotropin-releasing hormone (GnRH), which in turn drives LH and FSH. They also connect directly to the heat-control part of the hypothalamus, the median preoptic nucleus, which runs the body’s cooling responses.[3]
Estrogen normally keeps KNDy neuron activity down, especially the release of neurokinin B. When estrogen is withdrawn at menopause, that brake comes off. The KNDy neurons become overactive and physically enlarge, releasing too much neurokinin B.[2]
The Steps That Produce a Hot Flash
Neurokinin B binds to the NK3 receptor in the median preoptic nucleus. Neurons there connect to cooling pathways: they trigger widening of skin blood vessels, sweating, and a faster heart rate. These are the body’s normal responses to overheating, now fired by a faulty signal rather than by real heat.[3]
The sequence in real time:
- KNDy neurons fire in the hypothalamus
- Neurokinin B is released and reaches the median preoptic nucleus
- NK3 receptor activation triggers the cooling programme
- Skin blood vessels widen quickly (the flushing and warmth)
- Sweating starts as the body tries to cool skin that is suddenly getting more blood flow
- Heart rate rises to push blood to the skin
- Adrenaline is released as part of the arousal
- Core temperature may actually dip slightly, which is why some women feel cold after a flush
The whole event is driven from the brain. Core temperature before the flush is usually normal. The hypothalamus fires before any real overheating.
Why Swinging Estrogen Makes Hot Flashes Worse
This mechanism explains why early perimenopause, with its erratic estrogen spikes and crashes, tends to produce worse hot flashes than the steadier low-estrogen state of postmenopause. When estrogen swings widely, the KNDy neurons are turned down and then released again and again, repeatedly recalibrating the comfort zone. Each withdrawal sets off a spell of heightened sensitivity.
In settled postmenopause, with steadily low estrogen, the system reaches a new, lower equilibrium. Hot flashes continue but often become less frequent for many women in the years after the final period.
Why the Treatments Work
Estrogen replacement restores the brake on KNDy neurons, cutting neurokinin B release and returning the comfort zone toward normal. This is why HRT is the most effective treatment available: it targets the mechanism at its source.
Fezolinetant (the NK3 receptor blocker approved in 2023) stops neurokinin B from binding to its receptor in the median preoptic nucleus. It does not change KNDy neuron activity or neurokinin B levels, but it prevents the cooling pathways downstream from switching on. This produces roughly a 56 to 61% drop in hot flash frequency[4] without hormones.
SSRIs and SNRIs cut hot flash frequency through a different route: shifting serotonin and noradrenaline tone in the nervous system, which affects heat-control signalling indirectly. They are less effective than estrogen or fezolinetant but are an option for women who cannot use either, including women with hormone-sensitive cancers or reasons to avoid NK3 receptor blockers.
Alcohol, caffeine, stress, and warm rooms narrow the comfort zone further or add a heat or arousal trigger to a system already set to fire at the smallest push. Managing these triggers does not fix the mechanism, but it can meaningfully reduce how often events cross the threshold.
When to Seek Assessment
Hot flashes that happen seven or more times a day, disrupt sleep on most nights, or continue beyond ten years after the final period are worth a conversation with a clinician. Thresholds like these are used in trials to define who is a candidate for drug treatment, and they are a reasonable guide for seeking review. A clinician can also rule out non-menopausal causes (an overactive thyroid, carcinoid syndrome, certain medications) that cause flushing through other routes.
References
[1] Freedman, R. R., Krell, W. (1999). Reduced thermoregulatory null zone in postmenopausal women with hot flashes. American Journal of Obstetrics and Gynecology, 181(1), 66-70. https://doi.org/10.1016/S0002-9378(99)70432-4
[2] Rance, N. E., Dacks, P. A., Mittelman-Smith, M. A., Romanovsky, A. A., Krajewski-Hall, S. J. (2013). Modulation of body temperature and LH secretion by hypothalamic KNDy neurons: A novel hypothesis on the mechanism of hot flushes. Frontiers in Neuroendocrinology, 34(3), 211-227. https://pmc.ncbi.nlm.nih.gov/articles/PMC3833827/
[3a] Mittelman-Smith, M. A., Williams, H., Krajewski-Hall, S. J., Lai, J., Ciofi, P., McMullen, N. T., Rance, N. E. (2012). Arcuate kisspeptin/NKB/dynorphin neurons mediate the estrogen suppression of gonadotropin secretion and body weight. Endocrinology, 153(6), 2800-2812.
[3b] Role for KNDy neurons in cutaneous vasodilation and estrogen modulation. https://pmc.ncbi.nlm.nih.gov/articles/PMC3511761/
[4] Fraser, G. L., et al. (2023). Efficacy and safety of fezolinetant in moderate to severe vasomotor symptoms associated with menopause: a phase 3 RCT. Journal of Clinical Endocrinology & Metabolism. https://pmc.ncbi.nlm.nih.gov/articles/PMC10348473/
Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.